Navarrete RV (2009) Renal transplantation with living-donor surgical strategies: a view with 40 years of experience. Eur Urol 56(1):38–39. https://doi.org/10.1016/j.eururo.2009.02.018

Article  PubMed  Google Scholar 

Suthanthiran M, Strom TB (1994) Renal transplantation. N Engl J Med 331(6):365–376. https://doi.org/10.1056/NEJM199408113310606

Article  CAS  PubMed  Google Scholar 

Ingelfinger JR (2005) Agonistic autoantibodies and rejection of renal allografts. N Engl J Med 352(6):617–619. https://doi.org/10.1056/NEJMe048335

Article  CAS  PubMed  Google Scholar 

Methaneethorn J, Lohitnavy M, Onlamai K, Leelakanok N (2022) Predictive performance of published tacrolimus population pharmacokinetic models in Thai kidney transplant patients. Eur J Drug Metab Pharmacokinet 47(1):105–116. https://doi.org/10.1007/s13318-021-00735-8

Article  CAS  PubMed  Google Scholar 

Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43(10):623–653. https://doi.org/10.2165/00003088-200443100-00001

Article  CAS  PubMed  Google Scholar 

Kirubakaran R, Stocker SL, Hennig S, Day RO, Carland JE (2020) Population pharmacokinetic models of tacrolimus in adult transplant recipients: a systematic review. Clin Pharmacokinet 59(11):1357–1392. https://doi.org/10.1007/s40262-020-00922-x

Article  CAS  PubMed  Google Scholar 

Hoffert Y, Dia N, Vanuytsel T, Vos R, Kuypers D, Van Cleemput J, Verbeek J, Dreesen E (2024) Model-informed precision dosing of tacrolimus: a systematic review of population pharmacokinetic models and a benchmark study of software tools. Clin Pharmacokinet 63(10):1407–1421. https://doi.org/10.1007/s40262-024-01414-y

Article  CAS  PubMed  Google Scholar 

Holford N, Ma G, Metz D (2022) TDM is dead. Long live TCI! Br J Clin Pharmacol 88 (4): 1406–1413 https://doi.org/10.1111/bcp.14434

Wang CB, Zhang YJ, Zhao MM, Zhao LM (2023) Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review. Eur J Clin Pharmacol 79(7):897–913. https://doi.org/10.1007/s00228-023-03503-6

Article  CAS  PubMed  Google Scholar 

Lloberas N, Grinyo JM, Colom H, Vidal-Alabro A, Fontova P, Rigo-Bonnin R, Padro A, Bestard O, Melilli E, Montero N, Coloma A, Manonelles A, Meneghini M, Fava A, Torras J, Cruzado JM (2023) A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction. Kidney Int 104(4):840–850. https://doi.org/10.1016/j.kint.2023.06.021

Article  CAS  PubMed  Google Scholar 

Antignac M, Barrou B, Farinotti R, Lechat P, Urien S (2007) Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients. Br J Clin Pharmacol 64(6):750–757. https://doi.org/10.1111/j.1365-2125.2007.02895.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao CY, Jiao Z, Mao JJ, Qiu XY (2016) External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients. Br J Clin Pharmacol 81(5):891–907. https://doi.org/10.1111/bcp.12830

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin X, Rui J, Xia Y, Mu H, Song SH, Raja Aziddin RE, Miles G, Sun Y, Chun S (2018) Multi-center performance evaluations of tacrolimus and cyclosporine electrochemiluminescence immunoassays in the Asia-Pacific Region. Ann Lab Med 38(2):85–94. https://doi.org/10.3343/alm.2018.38.2.85

Article  CAS  PubMed  Google Scholar 

Xue L, Zhang H, Ma S, Rui JZ, Miao LY (2011) Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers. Pharmacology 88(5–6):288–294. https://doi.org/10.1159/000331856

Article  CAS  PubMed  Google Scholar 

Zhang HJ, Li DY, Zhu HJ, Fang Y, Liu TS (2017) Tacrolimus population pharmacokinetics according to CYP3A5 genotype and clinical factors in Chinese adult kidney transplant recipients. J Clin Pharm Ther 42(4):425–432. https://doi.org/10.1111/jcpt.12523

Article  CAS  PubMed  Google Scholar 

Vadcharavivad S, Praisuwan S, Techawathanawanna N, Treyaprasert W, Avihingsanon Y (2016) Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations. J Clin Pharm Ther 41(3):310–328. https://doi.org/10.1111/jcpt.12396

Article  CAS  PubMed  Google Scholar 

Han N, Ha S, Yun HY, Kim MG, Min SI, Ha J, Lee JI, Oh JM, Kim IW (2014) Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. Basic Clin Pharmacol Toxicol 114(5):400–406. https://doi.org/10.1111/bcpt.12176

Article  CAS  PubMed  Google Scholar 

Ansermot N, Fathi M, Veuthey JL, Desmeules J, Rudaz S, Hochstrasser D (2008) Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique. Clin Biochem 41 (10–11): 910–913 https://doi.org/10.1016/j.clinbiochem.2008.02.015

Sasano M, Kimura S, Maeda I, Hidaka Y (2017) Analytical performance evaluation of the Elecsys(R) Cyclosporine and Elecsys(R) Tacrolimus assays on the cobas e411 analyzer. Pract Lab Med 8:10–17. https://doi.org/10.1016/j.plabm.2017.03.001

Article  PubMed  PubMed Central  Google Scholar 

Storset E, Holford N, Midtvedt K, Bremer S, Bergan S, Asberg A (2014) Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol 70(1):65–77. https://doi.org/10.1007/s00228-013-1584-7

Article  CAS  PubMed  Google Scholar 

Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T (1995) Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29(6):404–430. https://doi.org/10.2165/00003088-199529060-00003

Article  CAS  PubMed  Google Scholar 

Sam WJ, Aw M, Quak SH, Lim SM, Charles BG, Chan SY, Ho PC (2000) Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. Br J Clin Pharmacol 50(6):531–541. https://doi.org/10.1046/j.1365-2125.2000.00288.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacobson P, Ng J, Ratanatharathorn V, Uberti J, Brundage RC (2001) Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients. Bone Marrow Transplant 28(8):753–758. https://doi.org/10.1038/sj.bmt.1703224

Article  CAS  PubMed  Google Scholar 

Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K (2001) Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Eur J Clin Pharmacol 57(6–7):479–484. https://doi.org/10.1007/s002280100331

Article  CAS  PubMed  Google Scholar 

Wallin JE, Friberg LE, Fasth A, Staatz CE (2009) Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: new initial dosage suggestions and a model-based dosage adjustment tool. Ther Drug Monit 31(4):457–466. https://doi.org/10.1097/FTD.0b013e3181aab02b

Article  CAS  PubMed  Google Scholar 

Xue L, Zhang WJ, Tian JX, Liu LN, Yan HH, Zhang WW, Ding XL, Zhang JJ, Miao LY (2019) Multicenter-based population pharmacokinetic analysis of ciclosporin in hematopoietic stem cell transplantation patients. Pharm Res 37(1):15. https://doi.org/10.1007/s11095-019-2740-2

Article  CAS  PubMed  Google Scholar 

Thelen K, Dressman JB (2009) Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol 61(5):541–558. https://doi.org/10.1211/jpp/61.05.0002

Article  CAS  PubMed  Google Scholar 

Kolars JC, Awni WM, Merion RM, Watkins PB (1991) First-pass metabolism of cyclosporin by the gut. Lancet 338(8781):1488–1490. https://doi.org/10.1016/0140-6736(91)92302-i

Article  CAS  PubMed